Cargando…

Patients’ motivations for participating in cardiovascular clinical trials: a local perspective

OBJECTIVE: To investigate patients’ motivations for participating in cardiovascular clinical trials. METHODS: Patients attending TREAD Research, located within Tygerberg Hospital, Parow, Western Cape, between January 2005 and May 2006 were approached to participate in the study. Consenting patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, LJ, Sulzer, NU, Hoosain, F, Leverton, N, Bliganut, S, Emanuel, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721774/
https://www.ncbi.nlm.nih.gov/pubmed/19701529
_version_ 1782278086769770496
author Burgess, LJ
Sulzer, NU
Hoosain, F
Leverton, N
Bliganut, S
Emanuel, S
author_facet Burgess, LJ
Sulzer, NU
Hoosain, F
Leverton, N
Bliganut, S
Emanuel, S
author_sort Burgess, LJ
collection PubMed
description OBJECTIVE: To investigate patients’ motivations for participating in cardiovascular clinical trials. METHODS: Patients attending TREAD Research, located within Tygerberg Hospital, Parow, Western Cape, between January 2005 and May 2006 were approached to participate in the study. Consenting patients were given a validated questionnaire to complete in their home language. All questionnaires were anonymous and 250 consecutive patients completed the questionnaire. They provided basic demographic data and rated their response to 18 statements concerning factors that may or may not have influenced their decision to participate in a clinical trial. RESULTS: The mean (± SD) age of subjects was 56.3 ± 10.9 years. A large percentage of the respondents were unemployed (66.5%). Access to medical care was a motivation for the majority of patients (90.5%). Ninety-six per cent of patients appreciated the regular follow up they received as trial participants; 90% of patients entered the trial to receive medication, which they could otherwise not afford. A substantial 98% of patients participated to learn more about their disease. Almost all (99%) wanted to further the scientific understanding of their condition. A reassuring 94% of subjects felt that they were not pressurised into the study; 80% of patients disagreed that participation in clinical trials was an easy way to obtain money. CONCLUSIONS: Access to medical care and making a contribution to scientific knowledge are two of the most common motivations for participation in cardiovascular clinical trials. The role of remuneration is relatively unimportant.
format Online
Article
Text
id pubmed-3721774
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-37217742013-08-07 Patients’ motivations for participating in cardiovascular clinical trials: a local perspective Burgess, LJ Sulzer, NU Hoosain, F Leverton, N Bliganut, S Emanuel, S Cardiovasc J Afr Cardiovascular Topics OBJECTIVE: To investigate patients’ motivations for participating in cardiovascular clinical trials. METHODS: Patients attending TREAD Research, located within Tygerberg Hospital, Parow, Western Cape, between January 2005 and May 2006 were approached to participate in the study. Consenting patients were given a validated questionnaire to complete in their home language. All questionnaires were anonymous and 250 consecutive patients completed the questionnaire. They provided basic demographic data and rated their response to 18 statements concerning factors that may or may not have influenced their decision to participate in a clinical trial. RESULTS: The mean (± SD) age of subjects was 56.3 ± 10.9 years. A large percentage of the respondents were unemployed (66.5%). Access to medical care was a motivation for the majority of patients (90.5%). Ninety-six per cent of patients appreciated the regular follow up they received as trial participants; 90% of patients entered the trial to receive medication, which they could otherwise not afford. A substantial 98% of patients participated to learn more about their disease. Almost all (99%) wanted to further the scientific understanding of their condition. A reassuring 94% of subjects felt that they were not pressurised into the study; 80% of patients disagreed that participation in clinical trials was an easy way to obtain money. CONCLUSIONS: Access to medical care and making a contribution to scientific knowledge are two of the most common motivations for participation in cardiovascular clinical trials. The role of remuneration is relatively unimportant. Clinics Cardive Publishing 2009-08 /pmc/articles/PMC3721774/ /pubmed/19701529 Text en Copyright © 2010 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Burgess, LJ
Sulzer, NU
Hoosain, F
Leverton, N
Bliganut, S
Emanuel, S
Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
title Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
title_full Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
title_fullStr Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
title_full_unstemmed Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
title_short Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
title_sort patients’ motivations for participating in cardiovascular clinical trials: a local perspective
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721774/
https://www.ncbi.nlm.nih.gov/pubmed/19701529
work_keys_str_mv AT burgesslj patientsmotivationsforparticipatingincardiovascularclinicaltrialsalocalperspective
AT sulzernu patientsmotivationsforparticipatingincardiovascularclinicaltrialsalocalperspective
AT hoosainf patientsmotivationsforparticipatingincardiovascularclinicaltrialsalocalperspective
AT levertonn patientsmotivationsforparticipatingincardiovascularclinicaltrialsalocalperspective
AT bliganuts patientsmotivationsforparticipatingincardiovascularclinicaltrialsalocalperspective
AT emanuels patientsmotivationsforparticipatingincardiovascularclinicaltrialsalocalperspective